301166 Stock Overview
Distributes and supplies antibodies and protein products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Shanghai Universal Biotech Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥30.54 |
| 52 Week High | CN¥38.93 |
| 52 Week Low | CN¥22.81 |
| Beta | 1.5 |
| 1 Month Change | -4.20% |
| 3 Month Change | 20.14% |
| 1 Year Change | -19.29% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -70.93% |
Recent News & Updates
We Think That There Are More Issues For Shanghai Universal BiotechLtd (SZSE:301166) Than Just Sluggish Earnings
Nov 05
Pinning Down Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) P/S Is Difficult Right Now
Oct 15Recent updates
We Think That There Are More Issues For Shanghai Universal BiotechLtd (SZSE:301166) Than Just Sluggish Earnings
Nov 05Pinning Down Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) P/S Is Difficult Right Now
Oct 15What Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) 25% Share Price Gain Is Not Telling You
May 08Shanghai Universal BiotechLtd's (SZSE:301166) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 03Shareholder Returns
| 301166 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -2.6% | -2.2% | -1.2% |
| 1Y | -19.3% | -7.7% | 11.8% |
Return vs Industry: 301166 underperformed the CN Healthcare industry which returned -7.7% over the past year.
Return vs Market: 301166 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 301166 volatility | |
|---|---|
| 301166 Average Weekly Movement | 7.8% |
| Healthcare Industry Average Movement | 8.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 301166 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301166's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 675 | Zhaowu Leng | www.univ-bio.com |
Shanghai Universal Biotech Co.,Ltd. distributes and supplies antibodies and protein products. The company offers antibodies, recombinant proteins, detection kits, antigens, and other products, as well as biochemical reagents, molecular biology reagents, and cell biology reagents.
Shanghai Universal Biotech Co.,Ltd. Fundamentals Summary
| 301166 fundamental statistics | |
|---|---|
| Market cap | CN¥2.63b |
| Earnings (TTM) | CN¥14.12m |
| Revenue (TTM) | CN¥1.17b |
186.6x
P/E Ratio2.3x
P/S RatioIs 301166 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301166 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.17b |
| Cost of Revenue | CN¥964.35m |
| Gross Profit | CN¥202.98m |
| Other Expenses | CN¥188.87m |
| Earnings | CN¥14.12m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 17.39% |
| Net Profit Margin | 1.21% |
| Debt/Equity Ratio | 0% |
How did 301166 perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield287%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 09:24 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai Universal Biotech Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|